Free Access
Issue
J Extra Corpor Technol
Volume 39, Number 1, March 2007
Page(s) 43 - 48
DOI https://doi.org/10.1051/ject/200739043
Published online 15 March 2007
  1. Helman DN, Morales DL, Edwards NM, et al. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg. 1999;68:1187–94. [CrossRef] [Google Scholar]
  2. Kherani AR, Cheema FH, Oz MC, et al. Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives? J Thorac Cardiovasc Surg. 2003;126:1634–5. [CrossRef] [Google Scholar]
  3. Morris RJ, Pochettino A, O’Hara M, Gardner TJ, Acker MA. Emergent mechanical support in the community: improvement with early transplant center referral. J Heart Lung Transplant. 2005;24:764–8. [CrossRef] [PubMed] [Google Scholar]
  4. Bowen FW, Carboni AF, O’Hara ML, et al. Application of “double bridge mechanical” resuscitation for profound cardiogenic shock leading to cardiac transplantation. Ann Thorac Surg. 2001;72:86–90. [CrossRef] [Google Scholar]
  5. Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg. 2000;12:220–8. [CrossRef] [Google Scholar]
  6. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–34. [CrossRef] [PubMed] [Google Scholar]
  7. Samuels LE, Darze ES. Management of acute cardiogenic shock. Cardiol Clin. 2003;21:43–9. [CrossRef] [Google Scholar]
  8. El-Banayosy A, Arusoglu L, Kizner L, et al. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant. 2000;19:964–8. [CrossRef] [PubMed] [Google Scholar]
  9. Rao V, Oz MC, Flannery MA, et al. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125:855–62. [CrossRef] [Google Scholar]
  10. Reinhartz O, Farrar DJ, Hershon JH, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg. 1998;116:633–40. [CrossRef] [Google Scholar]
  11. Morgan JA, Stewart AS, Lee BJ, Oz MC, Naka Y. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J. 2004;50:360–3. [CrossRef] [PubMed] [Google Scholar]
  12. Williams MR, Oz MC. Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg. 2001;71:S86–91. [CrossRef] [Google Scholar]
  13. Samuels LE, Kaufman MS, Thomas MP, et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14:288–93. [CrossRef] [PubMed] [Google Scholar]
  14. Anderson M, Acker M, Kasirajan V, et al. Mechanical circulatory support improves recovery outcomes in profound cardiogenic shock post acute myocardial infarction: a US multicenter study. Am J Cardiol. 2006;96:11H. [Google Scholar]
  15. Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg. 1996;111:773–82. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.